President Donald Trump on Thursday announced a new approach by the administration to boost in vitro fertilization and other fertility treatments, as well as a deal to lower the price of a common fertility drug.
Trump said EMD Serono, which manufactures the widely used fertility drug Gonal-F, has entered into a “most favored nation” agreement with the administration, under which the company agreed to offer U.S. prices in line with what other countries pay.
Senior administration officials earlier speaking to reporters said additionally that guidance from the Health and Human Services, Treasury and Labor departments is forthcoming that will allow employers to offer stand-alone coverage of IVF benefits to employees.
